| Target Price | $35.70 |
| Price | $35.11 |
| Potential |
1.68%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Sanara MedTech Inc 2027 .
The average Sanara MedTech Inc target price is $35.70.
This is
1.68%
register free of charge
$36.75
4.67%
register free of charge
$35.35
0.68%
register free of charge
|
|
| A rating was issued by 8 analysts: 0 Analysts recommend Sanara MedTech Inc to buy, 5 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Sanara MedTech Inc stock has an average upside potential 2027 of
1.68%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 103.12 | 119.31 |
| 18.98% | 15.70% | |
| EBITDA Margin | 11.45% | 15.86% |
| 103.82% | 38.48% | |
| Net Margin | -36.42% | 1.49% |
| 226.79% | 104.09% |
5 Analysts have issued a sales forecast Sanara MedTech Inc 2026 . The average Sanara MedTech Inc sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Sanara MedTech Inc EBITDA forecast 2026. The average Sanara MedTech Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Sanara MedTech Inc Analysts have issued a net profit forecast 2026. The average Sanara MedTech Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -4.35 | 0.19 |
| 284.96% | 104.37% | |
| P/E | 181.17 | |
| EV/Sales | 2.96 |
5 Analysts have issued a Sanara MedTech Inc forecast for earnings per share. The average Sanara MedTech Inc EPS is
This results in the following potential growth metrics and future valuations:
Sanara MedTech Inc...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 30 2026 |
| Freedom Broker |
Locked
➜
Locked
|
Locked | Jun 17 2026 |
| Lake Street |
Locked
➜
Locked
|
Locked | Apr 15 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 26 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 14 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 18 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 15 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 30 2026 |
|
Locked
Freedom Broker:
Locked
➜
Locked
|
Jun 17 2026 |
|
Locked
Lake Street:
Locked
➜
Locked
|
Apr 15 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 26 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 14 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 18 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 15 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


